Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid

Renuka Gupte, Anjaih Siddam, Yan Lu, Wei Li, Yuko Fujiwara, Nattapon Panupinthu, Truc Chi Pham, Daniel L. Baker, Abby L. Parrill, Mari Gotoh, Kimiko Murakami-Murofushi, Susumu Kobayashi, Gordon B. Mills, Gabor Tigyi, Duane D. Miller

    Research output: Contribution to journalArticlepeer-review

    19 Scopus citations

    Abstract

    Cyclic phosphatidic acid (CPA) is a naturally occurring analog of lysophosphatidic acid (LPA) in which the sn-2 hydroxy group forms a five-membered ring with the sn-3 phosphate. Here, we describe the synthesis of R-3-CCPA and S-3-CCPA along with their pharmacological properties as inhibitors of lysophospholipase D/autotaxin, agonists of the LPA5 GPCR, and blockers of lung metastasis of B16-F10 melanoma cells in a C57BL/6 mouse model. S-3CCPA was significantly more efficacious in the activation of LPA5 compared to the R-stereoisomer. In contrast, no stereoselective differences were found between the two isomers toward the inhibition of autotaxin or lung metastasis of B16-F10 melanoma cells in vivo. These results extend the potential utility of these compounds as potential lead compounds warranting evaluation as cancer therapeutics.

    Original languageEnglish (US)
    Pages (from-to)7525-7528
    Number of pages4
    JournalBioorganic and Medicinal Chemistry Letters
    Volume20
    Issue number24
    DOIs
    StatePublished - Dec 15 2010

    Keywords

    • Autotaxin
    • GPR92
    • Lysophosphatidic acid
    • Lysophospholipase D
    • NPP2

    ASJC Scopus subject areas

    • Biochemistry
    • Molecular Medicine
    • Molecular Biology
    • Pharmaceutical Science
    • Drug Discovery
    • Clinical Biochemistry
    • Organic Chemistry

    Fingerprint Dive into the research topics of 'Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid'. Together they form a unique fingerprint.

    Cite this